Application of acetylcholine to peripheral nerve terminals in the skin is a widely used test in studies of human small fiber functions. However, a detailed pharmacological profile and the subunit composition of nicotinic acetylcholine receptors in human C-fiber axons are not known. In the present study, we recorded acetylcholine-induced changes of the excitability and of the intracellular Ca 2+ concentration in C-fiber axons of isolated human nerve segments.
INTRODUCTION
The evaluation of unmyelinated C-fiber function in the peripheral human nervous system is not possible with conventional electrophysiological techniques. As an alternative, unmyelinated sympathetic efferents and nociceptive afferents can be tested by transdermal iontophoresis of acetylcholine (ACh) to nerve endings in human skin. In such experiments, ACh induces sweat production by activation of sympathetic sudomotor axons (Low et al. 1983 ) and flare by release of vasoactive neuropeptides from terminals of nociceptive afferents (Benarroch and Low 1991; Parkhouse and Le Quesne 1988; Walmsley and Wiles 1990 ).
Many investigators have used this technique for the evaluation of C-fiber function in diabetic
and other neuropathies (Caselli et al. 2003; Kilo et al. 2000; Low 1993; Walmsley and Wiles 1991) . Important components of the ACh-induced axon reflexes have been demonstrated already. First, a contribution of nicotinic receptors in the membrane of C-fiber axons is revealed by the antagonism of hexamethonium (Benarroch and Low 1991) . Second, the conduction of action potentials via axon collaterals to a region outside the area of ACh application has been confirmed by dermal anesthesia (Caselli et al. 2003) . However, to our knowledge, a detailed analysis of the subtype of nicotinic receptor involved in the generation RESULTS
C-fiber compound action potentials of isolated human sural nerve
Recordings of compound action potentials from isolated fascicles of human sural nerves have been described in detail (Lambert and Dyck 1993; Quasthoff et al. 1995) . A representative example of compound action potentials obtained in the present study is illustrated in Fig. 1 . Fast conducting A-fibers and slowly conducting C-fibers were separated by adjusting the stimulus strength (5 -500 µA) and the stimulus duration (0.1 -1 ms).
Quantitatively, the amplitude of the C fiber compound potential (Fig. 1C ) varied between 0.1 and 1.5 mV (0.56 ± 0.31 mV; mean ± s.d., n = 81). Compound C-fiber action potentials could be recorded for at least 48 h after the excision of the nerves when stored at 4°C.
Agonists at nAChRs enhance the excitability of human C-fiber axons
Changes in the excitability of human C-axons induced by ACh are revealed by threshold tracking. Three stimulus conditions were tested in succession, using 3 channels of the program QTRAC (Fig. 2) . When tested using a constant supramaximal stimulus, a small or no decrease in the amplitude of the C-fiber compound action potential was observed during bath application of 100 µM ACh (Fig. 2, channel 1) . However ACh induced an increase in the amplitude of the submaximal C-fiber compound potential. This change in the peak amplitude resulted in a reduction of the stimulus current (threshold current) necessary to maintain the submaximal peak at 40% of the maximum (Fig. 2, channel 2, 3) . A decrease in the threshold current in combination with a constant supramaximal stimulus-induced compound action potential clearly indicates an increase in the excitability of C-fiber axons.
In a series of experiments, concentration-response curves for agonists at nAChRs in unmyelinated human C-fiber axons were determined. A typical example for these experiments is illustrated in Fig. 3 . Nicotine was applied in ascending concentrations via the bathing solution. A small decrease of the threshold current was seen at the least effective concentration (3 µM). At higher concentrations, the tracking speed was not fast enough to maintain the submaximal compound action potential at a constant amplitude. Furthermore, at the highest concentration tested (30 µM), nicotine produced a decrease in the amplitude of the supramaximal response. As a consequence of these multiple effects (on threshold current, peak amplitude of submaximal and of supramaximal response), concentration-response curves were plotted for the minimal effective concentration, i.e. the lowest concentration at which agonists at nAChRs produce changes in threshold current only. The data are plotted in Fig. 4 and reveal a pharmacological profile with the following order of potency: epibatidine >> 5-Iodo-A-85380 > DMPP > nicotine > cytisine > acetylcholine. In addition, effects of choline (10 mM, an agonist at the α7 subtype of nAChRs) was tested on the excitability of C-fiber axons in four fascicles from three different human sural nerves. Application of choline to the bathing solution did not induce an increase in axonal excitability (Fig. 6A ).
In few experiments, the application time for agonists at nAChRs was prolonged for more than the usual 1-3 min. Under these conditions, receptor desensitization well known for nAChRs (e.g. Tan et al. 1998 in sympathetic ganglion neurons) was revealed. A typical experiment is illustrated in Fig. 5 . DMPP (30 µM) was applied to the bathing solution for 11 min. The effects of this agonist on the supramaximal stimulus-induced compound action potential, on the peak of the compound action potential produced by submaximal stimulation, and on the threshold current faded completely within this time period.
Pharmacological profile of nAChR antagonists
The various subunit compositions of nAChRs can be separated by pharmacological antagonists. Therefore, the effects of DHßE, mecamylamine, and of MLA (widely used antagonist for discrimination of α4/β2, α3/β4, and of α7 subunits) were tested on the increase in C-fiber excitability produced by epibatidine (10 nM). Representative experiments are illustrated in Fig. 6 B, C and a summary of the data is plotted in Fig. 7 . It was found that mecamylamine strongly reduced the epibatidine-induced increase in excitability in concentrations above 3 nM. In contrast, DHßE had a blocking effect when applied in concentrations about 1000 times higher as compared to mecamylamine. MLA antagonized the epibatidine-induced increase in axonal excitability only in concentrations higher than those effective at α7 subunits (Zhao et al. 2003) .
Effects on intracellular Ca 2+ concentration
Epibatidine was tested for effects on the free intracellular Ca ] i were blocked by mecamylamine (1 µM; n = 2; not illustrated).
Immunohistochemistry
The pharmacological profile described above indicates a contribution of α3 subunits to the effects of ACh on the excitability of human C-fiber axons (see Discussion). α3-subunits can be present in two subtypes of nAChRs. These subtypes are composed either of α3 plus β subunits or of α3 in combination with α5 and ß subunits. A separation of these two subunit combinations by a pharmacological profile is not clear cut (see Discussion). Therefore, in immunohistochemical studies, we analyzed unmyelinated axons in six different nerve fascicles for the presence of the α5 subunit of nAChRs. Unmyelinated axons were identified by immunostaining of peripherin, a neurofilament present in sensory and sympathetic C-fibers (Derer et al. 1989; Goldstein et al. 1991 ). Double staining of six different teased nerve fiber preparations with anti-α5 and anti-peripherin antibodies revealed co-localization of both proteins in many of the unmyelinated axons ( Fig. 9A , B). In contrast, myelinated nerve fibers (identified in images using light transmission) were not immuno-positive for α5-subunits
DISCUSSION

Axonal localization of nAChRs
Excitatory effects of ACh on unmyelinated fibers in the peripheral mammalian nervous system are known for many decades (Douglas and Ritchie 1960) and a depolarizing effect of ACh has been recorded in single mammalian sensory ganglion cells (Genzen et al. 2001; Liu et al. 1993; Wood and Docherty 1997) . Electrophysiological studies on single human or rat C-fiber axons have demonstrated that sensitivity to ACh can be found in unmyelinated sympathetic efferents (Schmidt et al. 1999 ) and in unmyelinated sensory afferents (Bernardini et al. 2001; Schmelz et al. 2003; Steen and Reeh 1993) . However, there is less agreement whether receptors for ACh are restricted to nerve endings or whether they are also functionally active in the trunk of an unmyelinated peripheral axon. For example, Diamond (Diamond 1959) has injected ACh intra-arterially into the rabbit's sural nerve in vivo, and he has found that it failed to excite fibers of which the axons but not the endings were exposed to the drug (citation in Douglas and Ritchie 1960). In contrast, direct depolarizing effects of ACh on unmyelinated axons were seen in the isolated rabbit vagus nerve (Armett and Ritchie 1963) and in human C-axons by the method of threshold tracking used in the present study. A possible explanation for these findings is that activation of axonal ACh receptors produces membrane depolarization and an increase in membrane excitability which is not sufficient for generation of action potentials. Alternatively, it has been discussed that damage of axons due to nerve transection produces abnormal chemosensitivity of the axonal membrane e.g. by insertion of receptors into the axonal membrane (Michaelis et al. 1997 ). We cannot disprove this hypothesis, however, effects of ACh on human C-axons were seen already one hour after transection of the sural nerves and an increase in the sensitivity to ACh was not observed in the following 48 hours. We assume that such a time-dependent effect should be seen if more and more channels are translocated from the cytoplasm to the axonal membrane.
Activation of nAChRs on non-neuronal cells in the surrounding of axons might contribute to an increase in axonal excitability e. g. by release of K + or of other chemical mediators. We cannot completely exclude this possibility, however, clear evidence for the presence of axonal nAChRs was found in our immunohistological studies (see Fig. 9 ).
Furthermore, in a previous study (Lang et al. 2002) 
Subunit composition derived from the pharmacological profile and immunohistochemistry
The isolated human nerve fascicles used in the present study enable a detailed pharmacological profile of ACh-induced changes in membrane excitability. The possible subtype composition of nAChRs present in unmyelinated axons in a peripheral human nerve can be derived from this profile. An important contribution of α2 or α4 subunits can be excluded because 5-Iodo-A-85380, an agonist about equipotent to epibatidine at the α4β2 subtype (Mukhin et al. 2000) was about 100 times less potent than epibatidine on human Cfiber axons (Fig. 4) . Furthermore, in cells which have been transfected with combinations of human α2β4 or α4β4, cytisine had much stronger effects as compared to DMPP (Stauderman et al. 1998 ). The opposite rank order of potency (DMPP > cytisine) was found in human Cfiber axons (Fig. 4) . Such a high sensitivity to DMPP has been observed in cells expressing a composition of human α3 and β2 or β4 subunits (Chavez-Noriega et al. 2000; Stauderman et al. 1998) .
Further clues for the functional importance of the α3 and β4 subunits comes from the rank order of potency for antagonists. The observation that mecamylamine is more potent than DHβE in blocking epibatidine-induced responses (see Fig. 6, 7) is compatible with the presence of α3 but not of α4 subunits (Chavez-Noriega et al. 2000; Harvey et al. 1996) . Also, DHβE is less potent at combinations of α3β4 as compared to α3β2 subunits (Harvey and Luetje 1996).
The immunohistochemical data indicate that the α5 subunit is also expressed by human C-fiber axons. Binding of the antibody against the α5 subunit was found in many of the unmyelinated axons in the human sural nerve fascicles (see Fig. 9 ). Whether α5 subunits contribute to the pharmacological profile is difficult to answer. Transfection of α3ß4 and α3β2 cell lines with the α5 subunit had little effect on their agonist sensitivities (Gerzanich et al. 1998; Nelson et al. 2001 ). On the other hand, a functional contribution of α5 subunits not only to agonist but also to antagonist sensitivity of natively expressed nAChR channels has been described for chick sympathetic ganglion neurons (Yu and Role 1998).
Our findings on human axons are in general accordance with observations made in the peripheral nervous system of other mammalian species. The importance of α3, α5, β2 and β4 subunits for peripheral autonomic neurons has been revealed in electrophysiological and/or immunohistochemical studies in rat superior cervical ganglia (Skok et al. 1999) , in guinea-pig myenteric neurons (Zhou et al. 2002) and in the autonomic nervous system of mice (Wang et al. 2002) . Furthermore, high levels of antibodies against the α3 subunit have been found in autoimmune autonomic neuropathies (Lennon et al. 2003; Vernino et al. 2000) . Also in afferent sensory neurons, expression of α3 and β4 has been found (Flores et al. 1996) .
A study on cultured DRG neurons from postnatal rats came to the conclusion that nicotinic responses in 77% of the large neurons and in 32% of the small neurons are caused by the α7 subunit of nAChRs (Genzen et al. 2001 ). We did not find functional evidence for activation of α7 subunits in unmyelinated human axons because two characteristics of this subunit i.e. activation by choline and blockade by low concentrations of MLA could not be observed. It is known that ACh-induced membrane currents induced by binding to the α7 subunit are rapidly desensitizing and the bath application used in the present study might be too slow for such an activation. In addition, developmental changes in the expression of nAChR subunits have been described (Zoli et al. 1995) which may explain differences between cultured postnatal rat DRGs and adult human axons. Sensory neurons in DRGs also express the α9 and α10 subunits of nAChRs (Lips et al. 2002) . A contribution of these subunits to the effect of ACh on human C-axons is unlikely because the pharmacological profile (Rothlin et al. 2003 ) is very different from the one observed in the present study.
Function of axonal nAChRs
Although ACh is clearly able to excite a variety of sensory receptors, the involvement of ACh in normal or pathological activation of unmyelinated nerve fibres remains to be established (Carr and Proske 1996) . The presence of nAChRs in the axonal membrane of human peripheral C-axons is another example for non-synaptic nicotinic receptors in neurons agonists at nAChRs should be tested for their potential ability to prevent the generation of ectopic action potentials at sites of peripheral nerve injury.
In conclusion, studies on isolated human nerve fascicles indicate that chemosensitivity to ACh expected at nerve terminals can be studied at the axonal membrane. The use of isolated human nerve fascicles in combination with threshold tracking enables the recording of a pharmacological profile of nAChRs in unmyelinated human axons. Based on these data, the possible subunit combination (α3, α5, and β4) can be derived. It is likely, that isolated human C-fiber axons can be useful for studies of abnormal sensitivity to ACh in neuropathies and may be a helpful supplement in quantitative sensory tests of small fiber functions. Fig. 3 ; a summary of data is illustrated in Fig. 7 .
FIG. 7. Concentration-response curves for antagonists at nAChRs in human C-fiber axons.
Antagonists at nAChRs were tested for an inhibitory effect against an increase in C-fiber excitability produced by epibatidine (10 nM, normalized to 100 %). All compounds were applied via the bathing solution for at least 10 min before the effects of epibatidine were tested (data in the plot show mean ± SEM; number of observations for each agonist are given in the inset to the right). 
